Arena Pharma (ARNA +4.1%) adds to sharp gains from yesterday as LifeSci Advisors publishes an...

|About: Arena Pharmaceuticals, Inc. (ARNA)|By:, SA News Editor

Arena Pharma (ARNA +4.1%) adds to sharp gains from yesterday as LifeSci Advisors publishes an upbeat note about the stock. LifeSci's main points include Arena possibly receiving a $1.2B one-time purchase price adjustment from its partner Eisai based on net sales of diet drug Belviq.